| GEMOX‐R regimen is a highly effective salvage regimen in patients with refractory/relapsing diffuse large‐cell lymphoma: a phase II study A López, A Gutiérrez, A Palacios, I Blancas, M Navarrete, M Morey, ... European journal of haematology 80 (2), 127-132, 2008 | 148 | 2008 |
| Membrane structure modulation, protein kinase Cα activation, and anticancer activity of minerval J Martínez, O Vögler, J Casas, F Barcelo, R Alemany, J Prades, T Nagy, ... Molecular pharmacology 67 (2), 531-540, 2005 | 114 | 2005 |
| xCELLigence system for real-time label-free monitoring of growth and viability of cell lines from hematological malignancies J Martinez-Serra, A Gutierrez, S Muñoz-Capó, M Navarro-Palou, T Ros, ... OncoTargets and therapy, 985-994, 2014 | 89 | 2014 |
| Synthesis and mass spectroscopy kinetics of a novel ternary copper (II) complex with cytotoxic activity against cancer cells M Barceló-Oliver, Á García-Raso, A Terrón, E Molins, MJ Prieto, V Moreno, ... Journal of inorganic biochemistry 101 (4), 649-659, 2007 | 89 | 2007 |
| Prognostic time dependence of deletions affecting codons 557 and/or 558 of KIT gene for relapse-free survival (RFS) in localized GIST: a Spanish Group for Sarcoma Research … J Martin-Broto, A Gutierrez, X Garcia-del-Muro, JA Lopez-Guerrero, ... Annals of oncology 21 (7), 1552-1557, 2010 | 85 | 2010 |
| Randomized phase II study of trabectedin and doxorubicin compared with doxorubicin alone as first-line treatment in patients with advanced soft tissue sarcomas: a Spanish group … J Martin-Broto, AL Pousa, R de Las Peñas, X García del Muro, A Gutierrez, ... Journal of Clinical Oncology 34 (19), 2294-2302, 2016 | 76 | 2016 |
| Long-term hematologic reconstitution and clinical evaluation of autologous peripheral blood stem cell transplantation after cryopreservation of cells with 5% and 10 … A Galmes, A Gutiérrez, A Sampol Mayol, M Canaro Hirnyk, M Morey, ... haematologica 92 (7), 986-989, 2007 | 72 | 2007 |
| Rituximab, gemcitabine and oxaliplatin: an effective regimen in patients with refractory and relapsing mantle cell lymphoma J Rodriguez, A Gutierrez, A Palacios, M Navarrete, I Blancas, J Alarcón, ... Leukemia & lymphoma 48 (11), 2172-2178, 2007 | 72 | 2007 |
| Minerval induces apoptosis in Jurkat and other cancer cells V Llado, A Gutierrez, J Martínez, J Casas, S Terés, M Higuera, A Galmés, ... Journal of cellular and molecular medicine 14 (3), 659-670, 2010 | 67 | 2010 |
| New prognosis score including absolute lymphocyte/monocyte ratio, red blood cell distribution width and beta‐2 microglobulin in patients with diffuse large B‐cell lymphoma … L Bento, A Díaz‐López, G Barranco, AM Martín‐Moreno, M Baile, A Martín, ... British journal of haematology 188 (6), 888-897, 2020 | 56 | 2020 |
| The repression of E2F-1 is critical for the activity of Minerval against cancer J Martínez, A Gutierrez, J Casas, V Llado, A Lopez-Bellan, J Besalduch, ... Journal of Pharmacology and Experimental Therapeutics 315 (1), 466-474, 2005 | 56 | 2005 |
| Nilotinib counteracts P-glycoprotein-mediated multidrug resistance and synergizes the antitumoral effect of doxorubicin in soft tissue sarcomas VH Villar, O Vögler, J Martínez-Serra, R Ramos, S Calabuig-Farinas, ... PloS one 7 (5), e37735, 2012 | 43 | 2012 |
| Assessment of safety and efficacy of combined trabectedin and low-dose radiotherapy for patients with metastatic soft-tissue sarcomas: a nonrandomized phase 1/2 clinical trial J Martin-Broto, N Hindi, A Lopez-Pousa, J Peinado-Serrano, R Alvarez, ... JAMA oncology 6 (4), 535-541, 2020 | 37 | 2020 |
| Oleanolic and maslinic acid sensitize soft tissue sarcoma cells to doxorubicin by inhibiting the multidrug resistance protein MRP-1, but not P-glycoprotein VH Villar, O Vögler, F Barceló, M Gómez-Florit, J Martínez-Serra, ... The Journal of nutritional biochemistry 25 (4), 429-438, 2014 | 34 | 2014 |
| Expression of COX-2 on Reed-Sternberg cells is an independent unfavorable prognostic factor in Hodgkin lymphoma treated with ABVD F Mestre, A Gutierrez, R Ramos, J Martinez-Serra, L Sánchez, G Matheu, ... Blood, The Journal of the American Society of Hematology 119 (25), 6072-6079, 2012 | 32 | 2012 |
| Gemcitabine and oxaliplatinum: an effective regimen in patients with refractory and relapsing Hodgkin lymphoma A Gutierrez, J Rodriguez, J Martinez-Serra, J Gines, P Paredes, F Garcia, ... OncoTargets and therapy, 2093-2100, 2014 | 30 | 2014 |
| Differential impact of relative dose-intensity reductions in diffuse large B-cell lymphoma treated with R-CHOP21 or R-CHOP14 A Gutiérrez, L Bento, AM Bautista-Gili, F Garcia, J Martinez-Serra, ... PloS one 10 (4), e0123978, 2015 | 26 | 2015 |
| Yondelis®(ET-743, Trabectedin) sensitizes cancer cell lines to CD95-mediated cell death: New molecular insight into the mechanism of action J Martínez-Serra, E Maffiotte, J Martín, T Bex, M Navarro-Palou, T Ros, ... European journal of pharmacology 658 (2-3), 57-64, 2011 | 26 | 2011 |
| Prognostic value of serum CA125 levels in diffuse large B‐cell lymphoma: potential role of a new sex‐and age‐adjusted reference value A Gutiérrez, J MARTÍNEZ‐SERRA, B Barceló, A Sampol, L Vinas, ... International journal of laboratory hematology 32 (6p2), 582-589, 2010 | 19 | 2010 |
| Fluorescence resonance energy transfer-based real-time polymerase chain reaction method without DNA extraction for the genotyping of F5, F2, F12, MTHFR, and HFE J Martinez-Serra, J Robles, A Nicolàs, A Gutierrez, T Ros, JC Amat, ... Journal of blood medicine, 99-106, 2014 | 18 | 2014 |
Simona SoveriniAssistant Professor, University of BolognaVerified email at unibo.it
